Patents by Inventor Maureen A. McLaughlin

Maureen A. McLaughlin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Vitamin D receptor activators and methods of making
    Patent number: 8377913
    Abstract: The invention relates to compounds that are vitamin D receptor activators, compositions comprising such compounds, methods of using such compounds and compositions, processes for preparing such compounds, and intermediates obtained during such processes.
    Type: Grant
    Filed: September 8, 2008
    Date of Patent: February 19, 2013
    Assignee: AbbVie Inc.
    Inventors: Thomas W. Von Geldern, Jufang H. Barkalow, David M. Barnes, Anthony R. Haight, John E. Hengeveld, Xiaofeng Li, Maureen A. McLaughlin, William T. Noonan, Zhonghua Pei, Jinshyun Ruth Wu-Wong
  • VITAMIN D RECEPTOR ACTIVATORS AND METHODS OF MAKING
    Publication number: 20090131379
    Abstract: The invention relates to compounds that are vitamin D receptor activators, compositions comprising such compounds, methods of using such compounds and compositions, processes for preparing such compounds, and intermediates obtained during such processes.
    Type: Application
    Filed: September 8, 2008
    Publication date: May 21, 2009
    Applicant: ABBOTT LABORATORIES
    Inventors: Thomas W. Von Geldern, Jufang H. Barkalow, David M. Barnes, Anthony R. Haight, John E. Hengeveld, Xiaofeng Li, Maureen A. McLaughlin, William T. Noonan, Zhonghua Pei, Jinshyun Ruth Wu-Wong
  • Process for the preparation of matrix metalloproteinase inhibitors
    Patent number: 6441189
    Abstract: The instant invention provides a process for the synthesis of matrix metalloproteinase inhibitors.
    Type: Grant
    Filed: December 13, 2001
    Date of Patent: August 27, 2002
    Assignee: Abbott Laboratories
    Inventors: Anne E. Bailey, David R. Hill, Chi-nung W. Hsiao, Ravi Kurukulasuriya, Steve Wittenberger, Todd McDermott, Maureen A. McLaughlin
  • Process for preparing 6-o-substituted erythromycin derivatives
    Patent number: 6437106
    Abstract: In one aspect, the invention relates to a process for preparing 6-O-substituted erythromycin derivatives comprising reacting 2′-substituted and optionally 4″-substituted 9-oxime erythromycin derivatives with an alkylating agent in the presence of a palladium catalyst and phosphine. In another aspect, the invention relates to processes for preparing 6-O-substituted erythromycin ketolides using the palladium-catalyzed alkylation reaction.
    Type: Grant
    Filed: March 3, 2000
    Date of Patent: August 20, 2002
    Assignee: Abbott Laboratories
    Inventors: Eric J. Stoner, Matthew J. Peterson, Yi-Yin Ku, Russell D. Cink, Arthur J. Cooper, Mahendra N. Deshpande, Tim Grieme, Anthony R. Haight, David R. Hill, Margaret Chi-Ping Hsu, Steven A. King, Marvin Robert Leanna, Elaine C. Lee, Maureen A. McLaughlin, Howard E. Morton, James J. Napier, Daniel J. Plata, Prasad S. Raje, Michael Rasmussen, David Riley, Jien-Heh J. Tien, Steven J. Wittenberger
  • Process for the preparation of matrix metalloproteinase inhibitors
    Publication number: 20020052511
    Abstract: The instant invention provides a process for the synthesis of matrix metalloproteinase inhibitors.
    Type: Application
    Filed: December 13, 2001
    Publication date: May 2, 2002
    Inventors: Anne E. Bailey, David R. Hill, Chi-Nung W. Hsiao, Ravi Kurukulasuriya, Steve Wittenberger, Todd McDermott, Maureen A. McLaughlin
  • Process for the preparation of matrix metalloproteinase inhibitors
    Publication number: 20020019539
    Abstract: The instant invention provides a process for the synthesis of matrix metalloproteinase inhibitors.
    Type: Application
    Filed: March 30, 2001
    Publication date: February 14, 2002
    Inventors: Anne E. Bailey, David R. Hill, Chi-Nung W. Hsiao, Ravi Kurukulasuriya, Steve Wittenberger, Todd McDermott, Maureen A. McLaughlin
  • Process for preparing chiral tetracyclic dopaminergic compounds
    Patent number: 5659037
    Abstract: A process for preparing a chiral tetracyclic compound of formula: ##STR1## wherein R is hydrogen or a C.sub.1 -C.sub.6 -alkyl group and Z is oxygen, sulfur or --CH.dbd.CH--, the compounds having uses as dopamine agonists. The process involves reacting a chiral starting material and subsequent chiral intermediates in a series of chirality-preserving synthetic reactions.
    Type: Grant
    Filed: June 5, 1995
    Date of Patent: August 19, 1997
    Assignee: Abbott Laboratories
    Inventors: Paul P. Ehrlich, Michael R. Michaelides, Maureen A. McLaughlin, Chi-Nung Hsaio